Bulletin Updates

Vital Chemtech has received approval from NSE – 14 Oct 2022

Oct 14, 2022

The primary utilisation of IPO funds will be to meet the incremental working capital needs of the company

The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »